Fact check · Version 1 · Sources checked
“An FDA aviptadil substance record or orphan designation is drug approval.”
This guide explains research. It was not independently medically reviewed, and it does not diagnose, prescribe, or recommend treatment.
Misleading
This statement leaves out a limit that changes its meaning.
A substance record identifies a substance. The two checked FDA orphan records state that the named orphan indications were not approved. Neither record approves a finished product.
- What this answer is based on
- This answer uses an official regulator record or a specific product label.
- Limits of this answer
- The exact FDA records checked September 12, 2026; this is not a complete product-level approval search. These limits show which substance, product, people, use, place, and time the answer covers. A different product or situation can have a different answer.
- Topic
- Whether a specific product has an approval or another official status.
Sources for this fact check
Show 3 sources
01FDA aviptadil substance identity recordU.S. Food and Drug Administration · Reference · 202602FDA aviptadil orphan designation for sarcoidosisU.S. Food and Drug Administration · Regulatory · 202603FDA aviptadil orphan designation for pulmonary arterial hypertensionU.S. Food and Drug Administration · Regulatory · 2026
- Sources checked by
- Site editor · Editorial review